BMRN
BioMarin Pharmaceutical (BMRN) Investor Questions
Review BioMarin Pharmaceutical (BMRN) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- BioMarin Pharmaceutical
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 72
- Annual revenue
- $3.22B
- Annual net income
- $348.90M
- Annual free cash flow
- $724.96M
BioMarin Pharmaceutical (BMRN) Investor Questions research
BioMarin Pharmaceutical trades under the ticker BMRN. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review BMRN through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.